DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo.
Dai MD, Wang YL, Fan J, Dai Y, Ji YC, Sun YM, Peng X, Li LL, Wang YM, Duan WH, Ding J, Ai J.
Dai MD, et al. Among authors: wang ym, wang yl.
Acta Pharmacol Sin. 2021 Sep;42(9):1498-1506. doi: 10.1038/s41401-020-00567-3. Epub 2020 Dec 7.
Acta Pharmacol Sin. 2021.
PMID: 33288861
Free PMC article.